UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934

Date of Report (Date of earliest event reported): March 23, 2021

 

VERDE BIO HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

 

Nevada

 

000-54524

 

30-0678378

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

5 Cowboys Way, Suite 300

Frisco, Texas 75034

(Address of Principal Executive Offices)

 

 

(972) 217-4080

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

 


 

Item 2.01 Completion of Acquisition or Disposition of Assets.

 

Completion of Acquisition

 

On March 29, 2021, Verde Bio Holdings, Inc. (the “Company”) announced that it had completed the acquisition of certain Overriding Royalty Interests (“Acquisition”) with a private seller whereby the Company purchased various mineral and oil and gas royalty interests in exchange for $150,000 in cash, (“Purchase Price”). The acquisition closed on March 23, 2021 with the effective date of the acquisition March 1, 2021.

 

A form of the Purchase Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K.

 

Item 9.01

 

Financial Statements and Exhibits.

 

Exhibits. The following exhibits are being filed herewith:

 

Exhibit Number

 

Description of Exhibits

10.1

 

Purchase and Sale Agreement

99.1

 

Press Release issued March 29, 2021


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 29th day of March, 2021.

 

 

VERDE BIO HOLDINGS, INC.

 

 

 

By:  

/s/ Scott A. Cox

 

 

 

Name: 

Scott A. Cox

 

 

 

Title:  

Chief Executive Officer